The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...

since the sleep apnea approval is specifically for people with obesity, it could lead to insurance coverage for those with ...

The federal agency authorized the use of the Eli Lilly & Co. weight loss drug for “treatment of moderate to severe ...

Zepbound is the first medication approved to treat patients with obstructive sleep apnea ... 1 drugs Ozempic and Wegovy, this class of medications has become wildly popular as weight-loss and ...

So it makes sense that weight loss drugs like Eli LIlly’s Zepbound are being explored as alternatives to traditional obstructive sleep apnea therapies. Dr. Glickman echoes this insight ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.